4.7 Letter

A case report of insulin-dependent diabetes as immune-related toxicity of pembrolizumab: presentation, management and outcome

Journal

CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 65, Issue 6, Pages 765-767

Publisher

SPRINGER
DOI: 10.1007/s00262-016-1835-4

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available